日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Relation between initial hypothermia, course of the hypothermia and mortality in patients with septic shock: a post-hoc analysis of the SEPSISPAM randomized trial

脓毒性休克患者初始体温过低、体温过低过程与死亡率的关系:SEPSISPAM随机试验的事后分析

Bordeau, Louis; Seegers, Valérie; Demiselle, Julien; Schortgen, Frédérique; Grelon, Fabien; Mégarbane, Bruno; Anguel, Nadia; Mira, Jean-Paul; Dequin, Pierre-François; Gergaud, Soizic; Weiss, Nicolas; Legay, François; Le Tulzo, Yves; Conrad, Marie; Coudroy, Remi; Gonzalez, Frédéric; Guitton, Christophe; Tamion, Fabienne; Tonnelier, Jean-Marie; Bedos, Jean Pierre; Der Linden, Thierry Van; Vieillard-Baron, Antoine; Mariotte, Eric; Pradel, Gaël; Lesieur, Olivier; Ricard, Jean-Damien; Hervé, Fabien; Cheyron, Damien du; Guerin, Claude; Mercat, Alain; Teboul, Jean-Louis; Radermacher, Peter; Asfar, Pierre; Fage, Nicolas

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.

抑制 CDK9 可增强维奈托克和阿扎胞苷联合治疗诱导的 AML 细胞死亡。

Wu Shuangshuang, Zhao Jianlei, Azmi Aaban Asfar, Gupte Avanti, Thibodeau Jenna, Liu Shuang, Yang Jinli, Wang Guan, Edwards Holly, Polin Lisa A, Kushner Juiwanna, Dzinic Sijana H, White Kathryn, Boerner Julie, Hüttemann Maik, Yang Jay, Wang Yue, Taub Jeffrey W, Ge Yubin

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies

KPT-9274(一种首创的PAK4和NAMPT双重抑制剂)在晚期实体恶性肿瘤患者中的首次人体I期研究

Razak, Albiruni; Mahipal, Amit; Diamond, Jennifer R; Ribas, Antoni; Berlin, Jordan David; Azmi, Asfar S; Mark, Tomer; Walker, Christopher J; Chai, Yi; Kashyap, Trinayan; Gudi, Girish; Naing, Aung

Evaluating the quality of online patient education materials for gastric adenocarcinoma

评估胃腺癌在线患者教育材料的质量

Ray, Trisha; Barrow, Taylor; Hamel, Lauren; Al Hallak, Najeeb; Azmi, Asfar S; Shields, Anthony; Kim, Steve; Tobon, Miguel; Beal, Eliza W

Advancing systemic therapy for biliary tract cancer: current strategies and emerging paradigms

推进胆道癌系统性治疗:当前策略与新兴范式

Choucair, Khalil; Chamseddine, Shadi; Azmi, Asfar; Philip, Philip A

RAPID-DASH: fast and efficient assembly of guide RNA arrays for multiplexed CRISPR-Cas9 applications

RAPID-DASH:用于多重 CRISPR-Cas9 应用的快速高效向导 RNA 阵列组装

Salaudeen, Asfar Lathif; Mateyko, Nicholas; de Boer, Carl G

The Importance of a Multidisciplinary Team Approach in a Rare Case of Antenatally Diagnosed Tonne-Kalscheuer Syndrome

多学科团队协作在罕见的产前诊断Tonne-Kalscheuer综合征病例中的重要性

Woody, Brittany; Asfar, Malek; Berra, Alexander; Chilukuri, Divya; Villarosa, Ruth; Madeswaran, Chandini; Friedman, Cameron; Kalra, Riya; Kumar, Deepak; Moran, Rocio; Youssef, Mariam

Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2Ar and NPM1-m AML

Menin 和 XPO1 联合抑制可协同增强 KMT2Ar 和 NPM1-m AML 的抗白血病活性。

Uddin, Md Hafiz; Dhiman, Sandhya; Han, Yufen; Aboukameel, Amro; Dhillon, Vikram; Aguillar, Jeff; Buck, Steven; Deol, Abhinav; Boerner, Julie L; Polin, Lisa; Kessler, Linda; Burrows, Francis; Yang, Jay; Azmi, Asfar S; Maciejewski, Jaroslaw P; Cutler, Jevon; Du, Yang; Balasubramanian, Suresh Kumar

ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma

ADT-030 是一种新型 PDE10 抑制剂,在胰腺导管腺癌中表现出强大的抗肿瘤活性。

Bandi, Dhana Sekhar Reddy; Nagaraju, Ganji Purnachandra; Sarvesh, Sujith; Foote, Jeremy B; Keeton, Adam B; Chen, Xi; Ramirez-Alcantara, Veronica; Holmes, Thomas; Akce, Mehmet; Singh, Anju; Powell, Craig M; Behera, Santosh; Azmi, Asfar S; Nurmemmedov, Elmar; Babic, Ivan; Gorman, Gregory S; Coward, Lori; Buchsbaum, Donald J; Maxuitenko, Yulia Y; Piazza, Gary A; El-Rayes, Bassel F

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges

靶向KRAS突变:调控癌症演变和治疗挑战

Choucair, Khalil; Imtiaz, Hafsa; Uddin, Md Hafiz; Nagasaka, Misako; Al-Hallak, Mohammad Najeeb; Philip, Philip A; El-Rayes, Bassel; Pasche, Boris C; Azmi, Asfar S